Материалов:
1 005 012

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 1005012

Страница 3 из 100502

Serological Analysis of Immunogenic Properties of Recombinant Meningococcus IgA1 Protease-Based Proteins
Kotelnikova O.V., Zinchenko A.A., Vikhrov A.A., Alliluev A.P., Serova O.V., Gordeeva E.A., Zhigis L.S., Zueva V.S., Razgulyaeva O.A., Melikhova T.D., Nokel E.A., Drozhzhina E.Y., Rumsh L.D.
Using the genome sequence of IgA1 protease of N. meningitidis of serogroup B, four recombinant
Characterization of reverse genetics-derived cold-adapted master donor virus a/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model
Isakova-Sivak I.
Live attenuated influenza vaccines (LAIV) offer significant advantages over subunit or split
Humoral and cellular immune responses to Yersinia pestis Pla antigen in humans immunized with live plague vaccine
Feodorova V.A.
. Conclusions/Significance: The Pla protein can serve as a biomarker of successful vaccination with LPV
A strategy to elicit m2e-specific antibodies using a recombinant h7n9 live attenuated influenza vaccine expressing multiple m2e tandem repeats
Mezhenskaya D.
molecule. The new recombinant H7N9+4M2e vaccine induced anti-M2e antibody responses and demonstrated
Safety and immunogenicity of cold-adapted recombinant influenza vector expressing ESAT-6 and Ag85A antigens of M. tuberculosis
Sergeeva M.V.
of ESAT-6 protein in MDCK cells infected by recombinant virus. After intranasal administration to mice
Modulation of immunogenicity and conformation of HA1 subunit of influenza a virus H1/N1 hemagglutinin in tubular immunostimulating complexes
Sanina N.
of vaccines against flu due to the availability of most antigenic sites which are conformational. Therefore, a
mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development [Технология мРНК как одна из перспективных платформ для разработки вакцины против SARS-CoV-2]
Ilyichev A.A.
with the production of vaccines based on inactivated viruses or recombinant proteins. This property is critically
Ectodomain pulling combines with fusion peptide inserting to provide cooperative fusion for influenza virus and HIV
Akimov Sergey A.
of the fusion protein ectodomains gives additional torque, which deforms the membrane and additionally
Polyprenyl Phosphates Induce a High Humoral and Cellular Response to Immunization with Recombinant Proteins of the Replicative Complex of the Hepatitis C Virus
Masalova O.V., Lesnova E.I., Onishchuk A.A., Ivanova A.M., Gerasimova E.V., Ivanov A.V., Narovlyansky A.N., Sanin A.V., Pronin A.V., Kushch A.A.
to the weak immunogenicity of biotechnological products. When immunizing mice with the recombinant proteins NS
Safety and immunogenicity of the gamtbvac, the recombinant subunit tuberculosis vaccine candidate: A phase II, multi-center, double-blind, randomized, placebo-controlled study
Tkachuk A.P., Bykonia E.N., Popova L.I., Kleymenov D.A., Semashko M.A., Chulanov V.P., Fitilev S.B., Maksimov S.L., Smolyarchuk E.A., Manuylov V.A., Vasina D.V., Gushchin V.A., Gintsburg A.L.
GamTBvac is a candidate tuberculosis vaccine with two fusion proteins, containing Ag85a, ESAT6, CFP

Страница 3 из 100502

Фасеты

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core